RPM International (RPM) Proxy Filing summary

Executive summary

• Annual Meeting scheduled for October 3, 2024, will be held virtually, allowing shareholders to vote and submit questions online.

• Key proposals include declassifying the board, electing directors, advisory vote on executive compensation, approval of a new equity plan, and auditor ratification.

• Record financial performance in fiscal 2024: net sales up 1.1% to $7.34B, net income up 22.9% to $588.4M, EPS up 22.6% to $4.56, and operating cash flow nearly doubled to $1.12B.

• 50th consecutive year of increased cash dividends, with a 10% increase in 2023.

• Ongoing MAP 2025 restructuring plan targets $465M in incremental EBIT by end of fiscal 2025, with $160M in run-rate benefits achieved in fiscal 2024.

• Stock repurchase program continued, with $55M spent in fiscal 2024.

Voting matters and shareholder proposals

• Proposal to amend the Certificate of Incorporation to require annual election of directors, phasing out the classified board over three years.

• Election of three Class II directors for one-year terms if declassification is approved.

• Advisory vote on executive compensation (Say-on-Pay).

• Approval of the 2024 Omnibus Equity and Incentive Plan, authorizing up to 5M shares for equity awards.

• Ratification of Deloitte & Touche LLP as independent auditor for fiscal 2025.

• Shareholder proposals for 2025 must be submitted by April 24, 2025, for inclusion in next year’s proxy.

Board of directors and corporate governance

• Board currently has 11 members, 10 of whom are independent; all committee members are independent.

• Board committees: Audit, Compensation, Governance and Nominating, and Executive.

• Lead Independent Director role established; annual board and CEO self-evaluations conducted.

• Board diversity and skills matrix includes leadership, finance, ESG, M&A, and cybersecurity experience.

• Proxy access by-law adopted, allowing significant long-term shareholders to nominate directors.

• Succession planning and director tenure reviewed annually.